Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;15(12):413-419.
doi: 10.5489/cuaj.7198.

Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management

Shipra Taneja  1   2   3 , Jen Hoogenes  1   2   3 , Marissa Slaven  4   5 , Anil Kapoor  1   2   3   4
Affiliations
Review

Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management

Shipra Taneja et al. Can Urol Assoc J. 2021 Dec.

Abstract

Introduction: Recent recreational legalization of cannabis has resulted in an increased interest in the therapeutic effects of cannabis use in cancer patients, with reports of its use in symptom management and as a risk factor for cancer development. The objective of this review was to evaluate the literature on the association of cannabis use with the risk of cancer development, symptom management, and therapeutic management in the urological cancer (UC) patient population.

Methods: A systematic search of databases and trial registries for papers published from January 1947 to March 2020 on cannabis, symptom and therapeutic management, and cancer development in UC patients was conducted. After screening of full-text articles, data were extracted for evaluation. Studies were eligible if they were in the clinical setting, included ≥5 UC patients, reported use of any cannabis variant, and were written in English.

Results: The search retrieved 2456 abstracts, of which 48 full-text articles were reviewed and 21 included in the review. Low-level evidence suggested a correlation between cannabis use and risk for development of testicular cancer. Some support existed for using cannabis for cancer pain and chemotherapy-induced nausea. There was inadequate evidence to substantiate cannabis use as a therapeutic agent for management of UCs. A lack of high-level evidence and robust methodology of the studies limited evaluation of the findings.

Conclusions: Given the paucity of data on cannabis use for therapeutic purposes in UC, large, prospective trials with adequate followup times to observe the effect of cannabis use on UCs are warranted to improve the evidence base.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors do not report any competing personal or financial interests related to this work.

Figures

Fig. 1
Fig. 1
Study flow diagram.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Pergam SA, Woodfield MC, Lee CM, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 2017;123:4488–97. doi: 10.1002/cncr.30879. - DOI - PMC - PubMed
    1. Urits I, Borchart M, Hasegawa M, et al. An update of current cannabis-based pharmaceuticals in pain medicine. Pain Ther. 2019;8:41–51. doi: 10.1007/s40122-019-0114-4. - DOI - PMC - PubMed
    1. Zaki P, Blake A, Wolt A, et al. The use of medical cannabis in cancer patients. J Pain Manage. 2017;10:353–62. https://www.researchgate.net/publication/324088950_The_use_of_medical_ca... .
    1. Dariš B, Verboten MT, Knez Ž, et al. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn J Basic Med Sci. 2019;19:14–23. doi: 10.17305/bjbms.2018.3532. - DOI - PMC - PubMed
    1. Shi S, Brant AR, Sabolch A, et al. False news of a cannabis cancer cure. Cureus. 2019;11:e3918. doi: 10.7759/cureus.3918. - DOI - PMC - PubMed

LinkOut - more resources